A strategy for the detection of benzodiazepine drugs using low‐resolution paper‐spray mass spectrometry for harm reduction drug checking

Abstract

AbstractThe ability to detect newly emerging substances is of great importance in reducing harms for people who use drugs. New psychoactive substances including novel benzodiazepines in the illicit drug supply have been linked to high rates of overdose deaths while complicating drug checking as an overdose prevention strategy. Paper‐spray mass spectrometry (PS‐MS) has emerged as a novel strategy to rapidly detect trace components in street drug samples. While targeted, low‐resolution PS‐MS methods have proven effective, newly emerging substances are often missed. To address this, a method was applied to low‐resolution full‐scan PS‐MS data to aid in the early detection and identification of novel benzodiazepines in the unregulated drug supply. Using the developed method, true positives rates of 0.89 and 0.75 were achieved for bromazolam and etizolam in street samples obtained in a community drug checking service. The applicability of the method was further demonstrated for a novel benzodiazepine, desalkylgidazepam, that has recently emerged in the illicit drug supply.